Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Virios Therapeutics, Inc. - Common Stock (NQ:VIRI)

0.1550 UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Virios Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 20, 2022 ↗
Upgrades 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
  
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
Good morning, investor! It's time to start the day with a breakdown of the biggest pre-market stock movers for Tuesday morning! 
Via InvestorPlace
News headline image
Virios Therapeutics Shares Tank After Failing Fibromyalgia Study ↗
 
Via Benzinga
News headline image
Earnings Scheduled For August 11, 2022 ↗
Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million. 
Via Benzinga
News headline image
Why O2Micro International Is Trading Higher By 7%; Here Are 25 Stocks Moving Premarket ↗
Gainers 
Via Benzinga
News headline image
Why KnowBe4 Shares Jumped Over 28%; Here Are 79 Biggest Movers From Yesterday ↗
Gainers Ventoux CCM Acquisition Corp. (NASDAQ: VTAQ) shares jumped 54.6% to settle at $7.05 on Monday. 
Via Benzinga
News headline image
Virios Therapeutics, Inc. Announces Pricing of Public Offering
From Virios Therapeutics, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Gainers Reshape Lifesciences (NASDAQ:RSLS) stock increased by 10.1% to $0.39 during Monday's after-market session. The company's market cap stands at $1.3 million. 
Via Benzinga
News headline image
Virios Therapeutics, Inc. Announces Proposed Public Offering
From Virios Therapeutics, Inc.
Via Business Wire
News headline image
US Markets Turn Higher As Dow Jumps Over 100 Points ↗
U.S. stocks traded higher in volatile trading toward the end of trading, with the Dow Jones gaining more than 100 points on Monday. 
Via Benzinga
News headline image
Dow, S&P 500 Drop In Volatile Trading Ahead Of Fed's Rate Decision ↗
U.S. stocks traded lower in volatile trading toward the end of trading, with the Dow Jones dropping around 40 points on Monday. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
  
Via Benzinga
News headline image
Analyzing Virios Therapeutics's Short Interest ↗
Virios Therapeutics's (NASDAQ:VIRI) short percent of float has risen 6.58% since its last report. The company recently reported that it has 53 thousand shares sold short, which is... 
Via Benzinga
News headline image
Why Is Virios Therapeutics (VIRI) Stock Down 71% Today? ↗
Virios Therapeutics (VIRI) stock is falling hard on Monday after revealing results from its Phase 2b Study of IMC-1 in Fibromyalgia. 
Via InvestorPlace
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
  On Monday, 429 stocks made new 52-week lows. 
Via Benzinga
News headline image
Why Virios Therapeutics Is Trading Lower By Over 71%, Here Are 55 Stocks Moving In Monday's Mid-Day Session ↗
Gainers MicroCloud Hologram Inc. (NASDAQ: HOLO) shares jumped 134.6% to $19.74. 
Via Benzinga
News headline image
US Stocks Open Lower; Housing Market Index Drops In September ↗
U.S. stocks traded lower this morning, after recording losses in the previous week. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
  
Via Benzinga
News headline image
Virios Therapeutics Announces Top-Line Results from Phase 2b Study of IMC-1 in Fibromyalgia
From Virios Therapeutics, Inc. (VIRI)
Via Business Wire
News headline image
Recap Of Monday's Biotech Catalysts - End Of the Day Summary ↗
 
Via Benzinga
News headline image
Virios Therapeutics Commences Mid-Stage Long-COVID Study ↗
Virios Therapeutics (Nasdaq: VIRI) has initiated patient dosing in its exploratory Long-COVID trial evaluating IMC-2 (valacyclovir + celecoxib). 
Via Benzinga
News headline image
Virios Therapeutics’ Announces Dosing of First Patient in IMC-2 Long-COVID Treatment Trial
From Virios Therapeutics, Inc. (VIRI)
Via Business Wire
News headline image
This Technology Stock Jumped 55% Following Q2 Results; Here Are 96 Biggest Movers From Yesterday ↗
Gainers Eargo, Inc. (NASDAQ: EAR) jumped 77.2% to close at $2.02. The FDA finalized rule enabling access to over-the-counter hearing aids. 
Via Benzinga
News headline image
Virios Therapeutics Announces Second Quarter 2022 Financial Results and Provides Corporate Update
From Virios Therapeutics, Inc.
Via Business Wire
News headline image
Virios Therapeutics, Inc. to Present at Investor Summit Group’s Q3 Virtual Conference
From Virios Therapeutics, Inc.
Via Business Wire
News headline image
Virios Therapeutics: The 'Virus Hypothesis' That Stands to Change the Lives of 10M Americans
Via ACN Newswire
News headline image
Virios Therapeutics: The 'Virus Hypothesis' That Stands to Change the Lives of 10M Americans
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
Virios Therapeutics to Report Second Quarter 2022 Financial Results and Provide Corporate Update on Thursday, August 11, 2022
From Virios Therapeutics, Inc.
Via Business Wire
News headline image
Virios Therapeutics (Nasdaq: VIRI) Advancing Potential Paradigm Shift in Fibromyalgia Treatment
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.